Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

50% of US drug launches in 2023 missed first-year revenue targets

The news: Half of US pharmaceuticals launched in 2023 underperformed their first-year forecasts, while 39% overperformed, according to an analysis from Trinity Life Sciences.

  • Trinity compared the sales performance of new product launches relative to their pre-launch first-year revenue forecasts.

You've read 0 of 2 free articles this month.

Get more articles - create your free account today!